Alzheimer's blood test could hit the market in early 2024, researchers say
A new blood test developed by Resonant achieved 100% accuracy in identifying patients with Alzheimer's disease and those with mild cognitive impairment (MCI) who went on to develop Alzheimer's within five years.
The test works by detecting the presence of DNA released from neurons in the blood, indicating neurodegeneration.
Researchers are also working to apply this technology to other neurodegenerative diseases, such as Parkinson's and ALS. [ more ]
The Biotech Company Battling Neurodegenerative Diseases | Entrepreneur
Howard's mission-driven approach in healthcare innovation stems from personal family experiences, leading to the founding of Coya Therapeutics. [ more ]